In the News
The Burrill Report interviews Greg Scott on WuXi/CRL breakup and China's hot IPOs
 
Greg Scott joined Foley's Eye on China webinar on life science innovation
>>Foley webinar...
Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

Asymchem Labs Ups its China Investment – Again

publication date: Dec 28, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Asymchem Laboratories is very much a company on the move. Headquartered in the Research Triangle Park of North Carolina, Asymchem makes chemical intermediates and APIs in six locations in China. So far, it has invested 1.7 billion RMB ($227 million) in its China facilities. Asymchem announced that it will put another 300 million RMB ($40 million) to work building a 100,000 square meter facility in the Dagang Development Zone (DEDA) of Tianjin, north China. This is in addition to the 480 million RMB ($64 million) it will spend on the Asymchem Life Science Co. facility, located in the Tianjin Economic-Technological Development Area (TEDA). More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
BioBay Investor Forum 2010
Suzhou, China
November 3 - 4, 2010
China Forum 2010
Munich, Germany
November 14, 2010

 
ChinaBio® Investor Forum 2010 - Guangzhou
Guangzhou, China
December 21, 2010
Partner Events
BioPharm America™ 2010
Boston, MA, USA
September 15–17, 2010

CALAsia 2010
San Diego, USA
October 4-5, 2010

CHINA PRETRIALS 2010: Global Preclinical Development Summit
Beijing, China
October 17-19, 2010

CHINA TRIALS 2010
Beijing, China
November 7-9, 2010

12th Shanghai International Forum on Biotechnology & Pharmaceutical Industry (BIO-FORUM)
Beijing, China
November 9-11, 2010
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners